Can a Century-Old TB vaccine stop bladder Cancer's return?
NCT ID NCT06747455
First seen Nov 19, 2025 · Last updated May 16, 2026 · Updated 15 times
Summary
This phase 3 study tests whether a therapeutic BCG vaccine can prevent bladder cancer from returning after surgery. About 439 adults with intermediate- or high-risk non-muscle-invasive bladder cancer will receive either BCG or an active control. The main goal is to see how many people remain cancer-free one year after treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BCG are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fudan University Shanghai Cancer Center
Shanghai, China
Conditions
Explore the condition pages connected to this study.